Project #3:
Vaccine Regression Discontinuity
The aim of the study is to estimate the effectiveness of the vaccines for COVID-19 using the age thresholds in the JCVI COVID-19 vaccination first phase priority groups under a modelling approach known as a regression discontinuity design.
- Study lead: Tom Palmer
- Organisation: University of Bristol
- Project type: Research
- View project progress, open code and outputs